Skip to content

OCUL

Ocular Therapeutix, Inc.

NASDAQ · USHealthcareBiotechnology
$8.71-2.90%

Price as of Jul 20, 2026

OCUL capital

Ocular Therapeutix, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.14x
Net debt / equity
-1.01x
Debt / assets
0.11x
Debt / EBITDA
-0.29x
Net debt / EBITDA
2.14x

Liquidity & coverage

Current ratio
14.81x
Quick ratio
14.73x
Cash ratio
13.98x
Interest coverage
-25.75x
EBITDA / interest
-23.59x
Working capital
$658.3M

Cash & dividend

FCF / debt
-3.03x
Cash flow / debt
-2.85x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.